IQ EQ FUND MANAGEMENT (IRELAND) Ltd

Position in PRME — Prime Medicine, Inc.

CIK 1620943 DUBLIN 2, L2

Position in PRME

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$833,198

+$118,445 QoQ

Shares Held

225,799

+9.9% QoQ

Ownership

0.124%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#43

of 186 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $72,560,422 across 12 Biotechnology names. PRME ranks #10 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	381,991	$20,833,789
2	BEAM	Beam Therapeutics Inc.	455,954	$15,648,341
3	NTLA	Intellia Therapeutics, Inc.	777,948	$13,162,880
4	RXRX	Recursion Pharmaceuticals, Inc.	2,604,317	$9,557,843
5	ABSI	Absci Corp	478,520	$5,546,046
6	NRIX	Nurix Therapeutics, Inc.	89,885	$2,180,610
7	ATAI	AtaiBeckley Inc.	252,913	$1,332,851
8	IONS	Ionis Pharmaceuticals Inc	15,819	$1,254,288

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$833,198	225,799	+9.9%	Shares	Sole	2026-07-31
2026-03-31	$714,753	205,389	+15.1%	Shares	Sole	2026-05-11
2025-12-31	$619,460	178,519	+47.8%	Shares	Sole	2026-02-12
2025-09-30	$669,082	120,773	+258.8%	Shares	Sole	2025-11-05
2025-06-30	$83,140	33,660	-62.5%	Shares	Sole	2025-08-01
2025-03-31	$178,841	89,870	+48.1%	Shares	Sole	2025-05-09
2024-12-31	$177,200	60,685	+115.9%	Shares	Sole	2025-02-12
2024-09-30	$108,797	28,113	+48.6%	Shares	Sole	2024-10-16
2024-06-30	$97,217	18,914	—	Shares	Sole	2024-07-29
No filing history on record for this holder in this stock.